AstraZeneca PLC (AZN)
162.70
-1.82
(-1.11%)
USD |
NYSE |
Aug 28, 16:00
162.67
-0.03
(-0.02%)
Pre-Market: 20:00
AstraZeneca Total Return Level : 410.68 for Aug. 28, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 28, 2026 | 410.68 |
| August 27, 2026 | 415.27 |
| August 26, 2026 | 419.69 |
| August 25, 2026 | 428.24 |
| August 24, 2026 | 420.80 |
| August 21, 2026 | 418.96 |
| August 20, 2026 | 415.19 |
| August 19, 2026 | 416.36 |
| August 18, 2026 | 404.11 |
| August 17, 2026 | 396.01 |
| August 14, 2026 | 394.90 |
| August 13, 2026 | 396.89 |
| August 12, 2026 | 400.08 |
| August 11, 2026 | 400.71 |
| August 10, 2026 | 408.68 |
| August 07, 2026 | 407.45 |
| August 06, 2026 | 403.88 |
| August 05, 2026 | 404.96 |
| August 04, 2026 | 390.22 |
| August 03, 2026 | 396.11 |
| July 31, 2026 | 425.37 |
| July 30, 2026 | 429.63 |
| July 29, 2026 | 434.55 |
| July 28, 2026 | 432.49 |
| July 27, 2026 | 425.37 |
| Date | Value |
|---|---|
| July 24, 2026 | 424.42 |
| July 23, 2026 | 421.94 |
| July 22, 2026 | 425.60 |
| July 21, 2026 | 424.62 |
| July 20, 2026 | 412.53 |
| July 17, 2026 | 423.52 |
| July 16, 2026 | 424.49 |
| July 15, 2026 | 422.19 |
| July 14, 2026 | 412.48 |
| July 13, 2026 | 424.95 |
| July 10, 2026 | 430.31 |
| July 09, 2026 | 447.56 |
| July 08, 2026 | 474.62 |
| July 07, 2026 | 484.25 |
| July 06, 2026 | 476.83 |
| July 02, 2026 | 489.34 |
| July 01, 2026 | 461.03 |
| June 30, 2026 | 475.47 |
| June 29, 2026 | 478.81 |
| June 26, 2026 | 472.44 |
| June 25, 2026 | 465.59 |
| June 24, 2026 | 458.92 |
| June 23, 2026 | 453.91 |
| June 22, 2026 | 442.40 |
| June 18, 2026 | 438.64 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| GSK Plc | 193.80 |
| Johnson & Johnson | 639.60 |
| Eli Lilly & Co. | 3103.57 |
| Merck & Co., Inc. | 456.06 |
| Novo Nordisk A/S | 81.62 |